Article
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.
Nature communications - 20 Feb 2015
Fibriansah Guntur, Tan Joanne L, Smith Scott A, de Alwis Ruklanthi, Ng Thiam-Seng, Kostyuchenko Victor A, Jadi Ramesh S, Kukkaro Petra, de Silva Aravinda M, Crowe James E, Lok Shee-Mei
Abstract excerpt
Dengue virus (DENV) infects ~400 million people annually. There is no licensed vaccine or therapeutic drug. Only a small fraction of the total DENV-specific antibodies in a naturally occurring dengue infection consists of highly neutralizing antibodies. Here we show that the DENV-specific human monoclonal antibody 5J7 is exceptionally potent, neutralizing 50% of virus at nanogram-range antibody concentration. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
